MAPK9 and cholestasis: The protective effects of fenofibrate and DCHT on ANIT-induced cholestasis and liver injury coincident with the inhibition of mRNA expression of inflammation-related genes (Il6, Il1b, and Tnfa), as well as the suppression of JNK/SAPK, NF-ĸB and STAT3 pathways.